Daniel Isaac is an Assistant Professor in the Division of Hematology and Oncology.
Dr. Isaac received his D.O. from Edward Via College of Osteopathic Medicine at Virginia Tech. He completed his residency in internal medicine at William Beaumont Hospital in Royal Oak, MI. Dr. Isaac completed his fellowship in Hematology/Oncology at MSU.
Dr. Isaac’s research at MSU has investigated the translational effects of TCH-165 and derivatives on relapsed multiple myeloma, as well as research on immune microenvironment modulation in prostate cancer.